
IndraLab
Statements
reach
"Since A-kinase-anchoring protein (AKAP) 79 XREF_BIBR, XREF_BIBR regulates CaM binding to KCNQ2 XREF_BIBR and serves as an adaptor protein for CaM and PKC XREF_BIBR, XREF_BIBR, the mechanism responsible for CaM mediated trafficking of KCNQ channels to the axonal surface may well converge with the ability of CaM to modulate PKC dependent inhibition of M-current via AKAP79/150 XREF_BIBR, XREF_BIBR and PIP 2 XREF_BIBR."
sparser
"To reveal the HN37 activation mechanism, we determined two KCNQ2-CaM structures in the presence of both HN37 and PIP 2 , one with HN37 added to the protein sample first (KCNQ2-CaM HN37-PIP2(-) , Table xref , Supplementary Fig. xref ) and the other one with PIP 2 added first (KCNQ2-CaM PIP2-HN37 , Table xref , Supplementary Fig. xref )."
reach
"In combination, the experiments presented in Figure 3, Figure 4, Figure 5 suggest that impairing CaM binding to Kv7.2 reduces the number of functional channels at the plasma membrane, but the functional channels that did reach plasma membrane are likely to still bind CaM, as suggested previously (41)."
sparser
"The process appears to require at least two steps; the first involves the transient association of CaM with KCNQ2, and in the second, the complex adopts an "active" conformation that is more stable and is that which confers the capacity to exit the endoplasmic reticulum."
sparser
"Here we report cryo-electron microscopy (cryo-EM) structures of human KCNQ2-CaM in complex with three activators, namely the antiepileptic drug cannabidiol (CBD), the lipid phosphatidylinositol 4,5-bisphosphate (PIP 2 ), and HN37 (pynegabine), an antiepileptic drug in the clinical trial, in an either closed or open conformation."
sparser
"Because PIP 2 can potentiate the activation of KCNQ channels by enhancing the E–M coupling, to capture an open-state KCNQ2, we solved the structure of the KCNQ2-CaM complex in the presence of 1 mM PIP 2 (KCNQ2-CaM PIP2(-) , where (-) indicates that PIP 2 was added in the protein sample but not observed in the structure throughout this paper) at 2.7 Å resolution (Supplementary Fig. xref , Table xref )."
sparser
"In the TMD, the high-quality map of KCNQ2-CaM CBD allows us to clearly resolve two CBD molecules located in the hydrophobic cleft formed by S6 from the first subunit (S6 I ), S5, pore helix (PH), and S6 from the second subunit (S5 II , PH II , and S6 II ), and S1 from the third subunit (S1 III ) (Fig. xref )."
sparser
"Structural comparison of KCNQ2-CaM CBD and KCNQ2-CaM apo reveals that the two CBDs induce a rotamer change of Trp236 in S5 II , which eliminates the potential clash with CBD A on one hand and facilitates the formation of a hydrogen bond with CBD B on the other hand (Fig. xref )."
sparser
"Second, structure alignment KCNQ2-CaM CBD and KCNQ2-CaM CBD-PIP2 shows that PIP 2 induces a further 3–4 Å shift of VSD (Fig. xref ), which completely destroys interactions of VSD and CaM, resulting in the release of CaM and HA/HB from the VSD, followed by the rotation of CaM and HA/HB, as well as the folding of S6 and HA into one continuous helix (Fig. xref )."
sparser
"Interestingly, two different KCNQ2-CaM F104A maps were reconstructed from one dataset, which were designated KCNQ2-CaM F104A-CBD-PIP2(-)-I and KCNQ2-CaM F104A-CBD-PIP2-II at 2.7 Å and 3.5 Å resolutions, respectively (Fig. xref , Table xref , Supplementary Figs. xref – xref , xref )."
sparser
"The differential distribution of the KCNQ2-CaM F104A-CBD-PIP2 particles with only CBD A bound in closed and open states indicates that with the presence of PIP 2 , (i) CBD A alone is able to stabilize some KCNQ2 channels in the open conformation, which accounts for ~20% of total channels, and (ii) CBD B further enhances this stabilization and dramatically increases the ratio of the open-conformation channels."
reach
"Because PIP can potentiate the activation of KCNQ channels by enhancing the E–M coupling, to capture an open-state KCNQ2, we solved the structure of the KCNQ2-CaM complex in the presence of 1 mM PIP (KCNQ2-CaM , where (-) indicates that PIP was added in the protein sample but not observed in the structure throughout this paper) at 2."
reach
"KCNQ2 and CaM complex were heterologously expressed in Human Embryonic Kidney (HEK) 293S suspension cells (Life Technologies, ATCC, #CRL-3022) maintained at 30 °C in SMM 293-TI complete medium (Sino Biological Inc.) supplemented with 2% fetal bovine serum (FBS, Yeasen Biotechnology (Shanghai) Co., Ltd.)."
reach
"Using immunocytochemistry and the cluster of differentiation 4 (CD4) membrane protein as a trafficking reporter, we demonstrate that fusion of KCNQ2 carboxy-terminal tail is sufficient to target CD4 protein to the axonal surface whereas inhibition of calmodulin binding to KCNQ2 abolishes axonal surface expression of CD4 fusion proteins by retaining them in the endoplasmic reticulum."
reach
"In contrast, the A343D mutation, which blocked CaM binding to KCNQ2 (XREF_FIG) XREF_BIBR, XREF_BIBR, abolished surface and intracellular expression of HA-KCNQ3 and KCNQ2 channels at the AIS and distal axons (XREF_FIG, XREF_FIG) and reduced the surface " Axon and Dendrite " ratio to below 1 (XREF_FIG)."
reach
"Although CaM can still interact with KCNQ3 subunits XREF_BIBR, XREF_BIBR, the A343D mutation, which abolished CaM binding to KCNQ2 (XREF_FIG), prevented surface and intracellular expression of intact HA-KCNQ3 and KCNQ2 channels at the AIS and distal axons (XREF_FIG - XREF_FIG), consistent with a recent study reporting altered neuronal distribution of heteromeric channels by the I340A mutation XREF_BIBR."
reach
"Since the R353G mutation in KCNQ2 reduces CaM binding to heteromeric KCNQ2 and KCNQ3 channels only by 20% XREF_BIBR, XREF_BIBR, our results suggest that a greater degree of impairment in CaM binding to KCNQ2 is needed to prevent targeting of heteromeric channels to the axonal surface."
sparser
"Using immunocytochemistry and the cluster of differentiation 4 (CD4) membrane protein as a trafficking reporter, we demonstrate that fusion of KCNQ2 carboxy-terminal tail is sufficient to target CD4 protein to the axonal surface whereas inhibition of calmodulin binding to KCNQ2 abolishes axonal surface expression of CD4 fusion proteins by retaining them in the endoplasmic reticulum."
sparser
"Although CaM can still interact with KCNQ3 subunits xref , xref , the A343D mutation, which abolished CaM binding to KCNQ2 ( xref ), prevented surface and intracellular expression of intact HA-KCNQ3/KCNQ2 channels at the AIS and distal axons ( xref – xref ), consistent with a recent study reporting altered neuronal distribution of heteromeric channels by the I340A mutation xref ."
sparser
"Both WT and dominant-negative CaM bind to the C terminus of KCNQ2 ( xref ) and (a) mutations in KCNQ2 that affect CaM binding, (b) expression of dominant-negative CaM, or (c) expression of a “CaM sponge” lead to retention of KCNQ2 homomeric channels in the ER ( xref ; xref ; xref )."
sparser
"In combination, the experiments presented in xref , xref , xref suggest that impairing CaM binding to Kv7.2 reduces the number of functional channels at the plasma membrane, but the functional channels that did reach plasma membrane are likely to still bind CaM, as suggested previously ( xref )."